United States Cerebrovascular Disease Market Report & Forecast 2021-2027
SKU ID : QYR-19695418 | Publishing Date : 13-Dec-2021 | No. of pages : 93
Detailed TOC of United States Cerebrovascular Disease Market Report & Forecast 2021-2027
1 Introduction to Research & Analysis Reports1.1 Cerebrovascular Disease Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Cerebrovascular Disease Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Cerebrovascular Disease Overall Market Size
2.1 United States Cerebrovascular Disease Market Size: 2021 VS 2027
2.2 United States Cerebrovascular Disease Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cerebrovascular Disease Players in United States Market
3.2 Top United States Cerebrovascular Disease Companies Ranked by Revenue
3.3 United States Cerebrovascular Disease Revenue by Companies
3.4 Top 3 and Top 5 Cerebrovascular Disease Companies in United States Market, by Revenue in 2020
3.5 Companies Cerebrovascular Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cerebrovascular Disease Players in United States Market
3.6.1 List of Tier 1 Cerebrovascular Disease Companies in United States
3.6.2 List of Tier 2 and Tier 3 Cerebrovascular Disease Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Cerebrovascular Disease Market Size Markets, 2021 & 2027
4.1.2 Carotid Endarterectomy
4.1.3 Carotid Angioplasty Or Carotid Artery Stenting
4.1.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
4.2 By Type - United States Cerebrovascular Disease Revenue & Forecasts
4.2.1 By Type - United States Cerebrovascular Disease Revenue, 2016-2021
4.2.2 By Type - United States Cerebrovascular Disease Revenue, 2022-2027
4.2.3 By Type - United States Cerebrovascular Disease Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Cerebrovascular Disease Market Size, 2021 & 2027
5.1.2 Academic & Research Institutes
5.1.3 Pharmaceutical & Biotechnology Companies
5.1.4 Hospitals & Diagnostic Centers
5.1.5 Contract Research Organizations
5.1.6 Others
5.2 By Application - United States Cerebrovascular Disease Revenue & Forecasts
5.2.1 By Application - United States Cerebrovascular Disease Revenue, 2016-2021
5.2.2 By Application - United States Cerebrovascular Disease Revenue, 2022-2027
5.2.3 By Application - United States Cerebrovascular Disease Revenue Market Share, 2016-2027
6 Cerebrovascular Disease Companies Profiles
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Details
6.1.2 Johnson & Johnson Business Overview
6.1.3 Johnson & Johnson Cerebrovascular Disease Introduction
6.1.4 Johnson & Johnson Cerebrovascular Disease Revenue in United States Market (2016-2021)
6.1.5 Johnson & Johnson Recent Developments
6.2 Amgen
6.2.1 Amgen Company Details
6.2.2 Amgen Business Overview
6.2.3 Amgen Cerebrovascular Disease Introduction
6.2.4 Amgen Cerebrovascular Disease Revenue in United States Market (2016-2021)
6.2.5 Amgen Recent Developments
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Details
6.3.2 GlaxoSmithKline Business Overview
6.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction
6.3.4 GlaxoSmithKline Cerebrovascular Disease Revenue in United States Market (2016-2021)
6.3.5 GlaxoSmithKline Recent Developments
6.4 Sanofi-Aventis
6.4.1 Sanofi-Aventis Company Details
6.4.2 Sanofi-Aventis Business Overview
6.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction
6.4.4 Sanofi-Aventis Cerebrovascular Disease Revenue in United States Market (2016-2021)
6.4.5 Sanofi-Aventis Recent Developments
6.5 Merck
6.5.1 Merck Company Details
6.5.2 Merck Business Overview
6.5.3 Merck Cerebrovascular Disease Introduction
6.5.4 Merck Cerebrovascular Disease Revenue in United States Market (2016-2021)
6.5.5 Merck Recent Developments
6.6 Sangamo BioSciences
6.6.1 Sangamo BioSciences Company Details
6.6.2 Sangamo BioSciences Business Overview
6.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction
6.6.4 Sangamo BioSciences Cerebrovascular Disease Revenue in United States Market (2016-2021)
6.6.5 Sangamo BioSciences Recent Developments
6.7 Aldagen
6.7.1 Aldagen Company Details
6.7.2 Aldagen Business Overview
6.7.3 Aldagen Cerebrovascular Disease Introduction
6.7.4 Aldagen Cerebrovascular Disease Revenue in United States Market (2016-2021)
6.7.5 Aldagen Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Figures, Tables and Charts Available in United States Cerebrovascular Disease Market Report & Forecast 2021-2027
List of TablesTable 1. Cerebrovascular Disease Market Opportunities & Trends in United States Market
Table 2. Cerebrovascular Disease Market Drivers in United States Market
Table 3. Cerebrovascular Disease Market Restraints in United States Market
Table 4. Key Players of Cerebrovascular Disease in United States Market
Table 5. Top Cerebrovascular Disease Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Cerebrovascular Disease Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Cerebrovascular Disease Revenue Share by Companies, 2016-2021
Table 8. Companies Cerebrovascular Disease Product Type
Table 9. List of Tier 1 Cerebrovascular Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cerebrovascular Disease Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – United States Cerebrovascular Disease Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Cerebrovascular Disease Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Cerebrovascular Disease Revenue (US$, Mn), 2022-2027
Table 14. By Application – United States Cerebrovascular Disease Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Cerebrovascular Disease Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Cerebrovascular Disease Revenue (US$, Mn), 2022-2027
Table 17. Johnson & Johnson Company Details
Table 18. Johnson & Johnson Business Overview
Table 19. Johnson & Johnson Cerebrovascular Disease Product
Table 20. Johnson & Johnson Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Johnson & Johnson Recent Developments
Table 22. Amgen Company Details
Table 23. Amgen Business Overview
Table 24. Amgen Cerebrovascular Disease Product
Table 25. Amgen Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Amgen Recent Developments
Table 27. GlaxoSmithKline Company Details
Table 28. GlaxoSmithKline Business Overview
Table 29. GlaxoSmithKline Cerebrovascular Disease Product
Table 30. GlaxoSmithKline Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. GlaxoSmithKline Recent Developments
Table 32. Sanofi-Aventis Company Details
Table 33. Sanofi-Aventis Business Overview
Table 34. Sanofi-Aventis Cerebrovascular Disease Product
Table 35. Sanofi-Aventis Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Sanofi-Aventis Recent Developments
Table 37. Merck Company Details
Table 38. Merck Business Overview
Table 39. Merck Cerebrovascular Disease Product
Table 40. Merck Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Merck Recent Developments
Table 42. Sangamo BioSciences Company Details
Table 43. Sangamo BioSciences Business Overview
Table 44. Sangamo BioSciences Cerebrovascular Disease Product
Table 45. Sangamo BioSciences Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Sangamo BioSciences Recent Developments
Table 47. Aldagen Company Details
Table 48. Aldagen Business Overview
Table 49. Aldagen Cerebrovascular Disease Product
Table 50. Aldagen Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Aldagen Recent Developments
List of Figures
Figure 1. Cerebrovascular Disease Segment by Type
Figure 2. Cerebrovascular Disease Segment by Application
Figure 3. United States Cerebrovascular Disease Market Overview: 2020
Figure 4. United States Cerebrovascular Disease Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Cerebrovascular Disease Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2020
Figure 7. By Type - United States Cerebrovascular Disease Revenue Market Share, 2016-2027
Figure 8. By Application - United States Cerebrovascular Disease Revenue Market Share, 2016-2027
Figure 9. Johnson & Johnson Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Amgen Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. GlaxoSmithKline Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sanofi-Aventis Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Merck Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Sangamo BioSciences Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Aldagen Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Keyplayers in United States Cerebrovascular Disease Market Report & Forecast 2021-2027
Johnson & JohnsonAmgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen